Effects of high-dose intravenous corticosteroid therapy in Landau-Kleffner syndrome.
Two children with Landau-Kleffner syndrome were successfully treated with antiepileptic drugs and a high-dose intravenous corticosteroid. A combination of valproate and a benzodiazepine (clonazepam or diazepam) ameliorated epileptic seizures and electroencephalographic spikes and waves, but speech disturbances persisted. Both patients were treated with an intravenous infusion of high-dose methylprednisolone sodium succinate (20 mg/kg daily) for 3 consecutive days. This infusion was repeated three times with a 4-day interval between treatments, which resulted in a rapid improvement in speech ability. After intravenous therapy, prednisolone was given orally (2 mg/kg daily for 1 month, then gradually withdrawn), which maintained the clinical improvement in speech.
Tsuru
T
T
Department of Pediatrics, Jichi Medical School, Tochigi, Japan.
Mori
M
M
Mizuguchi
M
M
Momoi
M Y
MY
D000284:Administration, Oral; D001037:Aphasia / Q000188:drug therapy; D002648:Child; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D018887:Landau-Kleffner Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D020551:Pulse Therapy, Drug; D020127:Recovery of Function; D016896:Treatment Outcome
D005938:Glucocorticoids; D011239:Prednisolone; D008775:Methylprednisolone